Breaks Categories: Stock Spotlights

WednesdayMar 15, 2017 12:08 pm

NetworkNewsBreaks – UGE International Ltd. (UGEIF) Shares Spike on New Contract for NYC’s First Community Solar Project

Shares of UGE International (OTCQB: UGEIF) are ticking higher after the clean energy company said it has secured a contract to develop and build New York City's first community solar project at a multi-tenant commercial facility in Brooklyn. Located in a neighborhood between Park Slope and Boerum Hill, the project will have a rated peak capacity of approximately 100 kilowatts, providing clean energy to be net metered and sold to residential off-takers at rates lower than their utility payments. The project is the first of several under development by UGE and Gotham Community Solar LLC, a company owned by Peter…

Continue Reading

WednesdayMar 15, 2017 11:40 am

NetworkNewsBreaks – Cesca Therapeutics (NASDAQ: KOOL) Spike on Encouraging Data for Chronic Non-Healing Ulcers Treatment

Shares of Cesca Therapeutics’ (NASDAQ: KOOL) are up 12% mid-morning on promising data from a study evaluating the use of autologous platelet rich plasma (PRP) for the treatment of chronic non-healing ulcers. The study, entitled “Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series,” was led by researchers from TotipotentRX, a subsidiary of Cesca Therapeutics, and Fortis Memorial Research Institute. Results from the 24 patient study were published in the peer-reviewed Journal of Biomedical Science. During the study, 24 patients with one wound or ulcer were treated with a single dose of PRP injections around the…

Continue Reading

WednesdayMar 15, 2017 11:38 am

NetworkNewsBreaks – Catalyst Pharmaceuticals (NASDAQ: CPRX) Shares Rally on Positive Data from Investigator-Sponsored Trial of Firdapse®

Shares of Catalyst Pharmaceuticals (NASDAQ: CPRX) are up more than 40% this morning following the company’s release of positive top-line results from the investigator-sponsored trial evaluating Firdapse® as a treatment for myasthenia gravis (MG) patients with anti-MuSK antibodies (MuSK-MG). MuSK-MG is an extremely rare form of MG with no FDA approved therapies currently available. Both of the co-primary efficacy endpoints of change from baseline (CFB) in total quantitative myasthenia gravis score and CFB in total myasthenia gravis activities of daily living score were statistically and clinically significant in this trial. Several secondary efficacy measures also achieved statistical significance, and the…

Continue Reading

TuesdayMar 14, 2017 2:31 pm

NetworkNewsBreaks – QuickLogic Corp. (NASDAQ: QUIK) Integrates Amazon “Alexa” Voice Trigger in EOS™ S3 Platform

Shares of QuickLogic (NASDAQ: QUIK) are up 4% in afternoon trade following early news that the company has integrated and optimized the "Alexa" voice trigger in hardware in the EOS™ S3 sensor processing platform running the Sensory TrulyHandsfree™ technology. Providing this capability in an ultra-low power device enables mobile and IoT design engineers to connect battery-powered devices to the Alexa ecosystem using the Alexa Voice Service (AVS) program offered by Amazon. The AVS program enables developers to convert any product with a microphone and speaker into one with "intelligent voice control" through a connection to Amazon servers running Artificial Intelligence…

Continue Reading

TuesdayMar 14, 2017 2:29 pm

NetworkNewsBreaks – RGS Energy (NASDAQ: RGSE) Awarded as Exclusive Installer for Solarize Granby Campaign

RGS Energy (NASDAQ: RGSE) this morning said it was selected by Solarize Granby, a non-profit purchasing cooperative, to bring solar electricity to homes and business owners in Granby, Connecticut. Solarize Granby’s objective is to increase the number of homeowners in Granby adopting a clean energy solution while also decreasing their electricity costs. The township of Granby consists of approximately 10,000 homeowners. RGS Energy anticipates the campaign to commence on April 5th and run through the beginning of August. “This solarize program marks the 40th time in our history we have been awarded a community solarize campaign, since we began as…

Continue Reading

MondayMar 13, 2017 10:41 am

NetworkNewsBreaks – ParkerVision, Inc. (NASDAQ: PRKR) Shares Sink on Motion to Terminate ITC Investigation

Shares of ParkerVision (NASDAQ: PRKR) are down 17% following the company’s early announcement that it is filing a motion to terminate its International Trade Commission (ITC) investigation in light of a recent ruling by the Administrative Law Judge (ALJ) disallowing key factual evidence in the company’s proceedings. The company was informed of this confidential ruling just prior to the start of the ITC hearing, which is scheduled to begin today. ParkerVision stated that it remains prepared to try its case based on evidence obtained in the investigation, however, the recent ruling excluding material portions of the company’s evidence resulted in…

Continue Reading

FridayMar 10, 2017 11:09 am

NetworkNewsBreaks – MySize, Inc. (NASDAQ: MYSZ) Developing New Measurement App to Support “Off-Line” Shopping

MySize (NASDAQ: MYSZ) this morning said it has started the development of a new application intended to support “off-line” shopping. The developer of proprietary smartphone measurement applications is developing the new application, which has yet to be branded, to support on site retail sales. The new application would be used by sales people in physical stores to create a measurement profile for the customer that they can then use for future purchases, both on- and off-line. This is likely to encourage return visits and increase customer loyalty and retention. "To date, it's been all about the online clothes shopping, which…

Continue Reading

FridayMar 10, 2017 10:25 am

NetworkNewsBreaks – Singlepoint, Inc. (SING) CEO Discusses Company’s Activity in the Cannabis Industry on MoneyTV

Full-service mobile technology and marketing provider Singlepoint, Inc. (OTC: SING) is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, Singlepoint CEO Greg Lambrecht discusses the company’s growing presence in the legal cannabis market. “While we’re waiting for the banks to open up, we’re finding other products that we can put in the dispensary. If you go to our SingleSeed.com site, you can see the stats specifically for dispensaries. So there’re really a…

Continue Reading

WednesdayMar 08, 2017 11:44 am

NetworkNewsBreaks – Innovus Pharma (INNV) Receives Notification to Commercialize Sensum+® in the EU; Shares Surge

Shares of Innovus Pharmaceuticals (OTCQB: INNV) are 41% higher mid-morning after the company said it has received the CPNP notification number required to commercialize Sensum+® in all 28 member countries of the European Union. Sensum+® is currently approved to be marketed and sold in 31 countries worldwide, including the United States, Europe, India and Morocco. The company also recently received the CPNP notification number to commercialize Zestra® in the EU on March 2, 2017.  “Now that we have received the CPNP notification numbers for Sensum+® and for Zestra®, which we announced last week, Innovus has two products ready to be…

Continue Reading

WednesdayMar 08, 2017 10:38 am

NetworkNewsBreaks – ParkerVision, Inc. (NASDAQ: PRKR) Shares Climb on Favorable Decision by PTAB in Final Qualcomm (NASDAQ: QCOM) IPR

Shares of ParkerVision, Inc. (NASDAQ: PRKR) are up 33% this morning on news the Patent Trial and Appeal Board (PTAB) has issued its latest favorable decision for the company in regard to the petitions for Inter Partes Review (IPR) filed by Qualcomm (NASDAQ: QCOM) against ParkerVision patents. Today’s news increases the favorable decisions for the company to over six out of the ten petitions originally filed. There are no further IPR’s challenging ParkerVision patents currently before the PTAB. “We continue to take positive steps forward in our Qualcomm proceedings and believe these results are indicative of the strength of ParkerVision’s…

Continue Reading